Is this you?

The Lyme treatment helped, and then it stopped helping.

Night sweats nobody asked about. Pain in the soles of your feet in the morning. Anxiety that arrived out of nowhere, in a life that was not anxious before. You were treated for one organism. The tick did not carry only one.

How it shows up

How co-infections change the picture

When co-infections are present alongside Borrelia, the clinical picture becomes more complex and severe. Patients with co-infections typically experience more intense symptoms, slower response to treatment, and greater diagnostic confusion.

Signs that co-infections may be present include:

  • Symptoms that do not improve with standard Lyme treatment
  • Air hunger, shortness of breath, or sighing respirations (Babesia)
  • Severe anxiety, rage episodes, or psychiatric symptoms (Bartonella)
  • Burning pain in the soles of the feet (Bartonella)
  • Drenching night sweats and temperature instability (Babesia)
  • Stretch-mark-like skin striations (Bartonella)
  • Sudden onset of high fever with body aches (Ehrlichia/Anaplasma)
  • Eye symptoms: floaters, blurred vision, light sensitivity
  • Encephalopathy and severe cognitive impairment beyond typical Lyme
  • Cyclic fevers or symptom patterns
Abstract teal and navy visual
Testing

How do you test for Bartonella and Babesia?

Babesia is looked for in the blood smear and by PCR, with serology as a second line; Bartonella by serology and PCR. Both can be negative in a long-standing infection, so the result is read with the symptom pattern. A standard Lyme work-up usually does not include them, although ticks frequently carry several pathogens at once (Sanchez-Vicente et al., 2019) and Babesia co-infection has been measured in tick-borne disease patients (Nijjar et al., 2024). The co-infection panel is part of every Lyme work-up at the hospital.

Rarely tested

Most physicians who diagnose Lyme disease do not order co-infection testing. The work-up stops at Borrelia, and the second and third organisms from the same bite stay invisible.

Test sensitivity

Antibody tests for co-infections share the limits of the Lyme antibody test: they can miss infections in patients with a suppressed immune response, and several of the organisms are hard to culture or to find by PCR in a routine blood sample.

Symptom overlap

Co-infection symptoms overlap with Lyme symptoms and with each other. Night sweats, air hunger and burning soles are the clues that point past Borrelia; without them being asked about, the plan stays incomplete.

Diagram of the tick life cycle and transmission point: egg, larva, nymph and adult around a ring with arrows
Tick life cycle and where people are infected. Schematic, not to scale.
The conditions explained

Which co-infections travel with Lyme disease?

Bartonella

Bartonella species (particularly B. henselae and B. quintana) are intracellular bacteria. The established routes to humans are cat scratches and bites and cat fleas for B. henselae, and body lice for B. quintana. Bartonella DNA has been found in ticks, but transmission by a tick bite to humans is debated and has not been established (Telford and Wormser, 2010). Because it can cause a similar multi-system picture, Bartonella is part of the co-infection panel for patients whose symptoms persist after Lyme disease.

Bartonella has a particular affinity for endothelial cells (blood vessel lining) and red blood cells, which explains its wide-ranging vascular and neurological symptoms. It can cause vasculitis, neuroinflammation, and psychiatric manifestations that are frequently misdiagnosed as primary mental health conditions.

Characteristic Symptoms

  • Burning pain, especially in the soles of the feet
  • Anxiety, agitation, rage episodes, depression
  • Subcutaneous nodules and stretch-mark-like striations
  • Swollen lymph nodes
  • Eye inflammation and visual disturbances
  • Headaches and neck stiffness
  • Encephalopathy and seizures in severe cases

Treatment approach

Bartonella requires specific antibiotic combinations, typically including agents that achieve high intracellular concentrations such as azithromycin, rifampin, or fluoroquinolones. Treatment duration is often longer than for Borrelia alone, and response monitoring is essential.

Diagram of Borrelia and common co-infections linked by vector: Borrelia at the center
Borrelia and common co-infections, by route of transmission.

Babesia: a parasite, not Lyme disease

Babesia species (B. microti, B. duncani and others) are protozoan parasites that infect red blood cells, like the malaria parasite. Babesia is transmitted by the same Ixodes ticks that carry Borrelia and is found together with it. Because it is a parasite, it does not respond to the antibiotics used for Lyme disease; the babesiosis guideline recommends antiparasitic combinations (Krause et al., 2021).

Babesiosis causes hemolysis as parasites rupture red blood cells, which explains the air hunger, drenching sweats and profound fatigue. It can be severe in immunocompromised patients and is harder to clear when Borrelia is present at the same time.

Characteristic Symptoms

  • Air hunger and shortness of breath at rest
  • Drenching night sweats and chills
  • Severe fatigue disproportionate to activity
  • Dark urine from hemoglobin release
  • Headaches, particularly frontal
  • Temperature instability and cyclic fevers
  • Vivid dreams and sleep disturbances

Treatment approach

Babesia is treated with antiparasitic agents, typically atovaquone with azithromycin or clindamycin with quinine. Treatment continues until the parasitemia clears and the symptoms settle, which often takes longer than the Borrelia course.

Ehrlichia & Anaplasma

Ehrlichia and Anaplasma are obligate intracellular bacteria that infect white blood cells. Ehrlichia chaffeensis infects monocytes (human monocytic ehrlichiosis), while Anaplasma phagocytophilum infects granulocytes (human granulocytic anaplasmosis). Both are transmitted by ticks and can cause acute and chronic illness.

These infections directly compromise immune function by infecting the very cells responsible for fighting infection. This immune suppression can make concurrent Borrelia infection more difficult to clear and can mask the typical immune responses used for serological diagnosis.

Characteristic Symptoms

  • High fever, often with sudden onset
  • Severe headache and muscle pain
  • Low white blood cell count (leukopenia)
  • Elevated liver enzymes
  • Low platelet count (thrombocytopenia)
  • Fatigue and malaise

Treatment approach

Doxycycline is the first-line treatment for both Ehrlichia and Anaplasma. In chronic co-infection, longer treatment courses are often necessary, and monitoring of white blood cell counts and liver function guides treatment duration.

Testing in the hospital laboratory

  • Laboratory analyser being operated in the clinic laboratory
    Blood diagnostics in the clinic laboratory · Clinicum St. Georg
  • Blood sample tube held in a gloved hand in the laboratory
    A blood sample in the clinic laboratory · Clinicum St. Georg

Other Co-Infections

Beyond the major tick-borne co-infections, chronic Lyme patients frequently harbor additional opportunistic infections that contribute to their symptom burden and complicate recovery:

  • Rickettsia: causes Rocky Mountain spotted fever and other rickettsial diseases, with vasculitis, rash and systemic inflammation.
  • Mycoplasma pneumoniae: a cell-wall-deficient bacterium seen with fatigue, respiratory symptoms, joint pain and neurological involvement in chronic infection.
  • Chlamydia pneumoniae: an intracellular bacterium seen with chronic fatigue, respiratory symptoms and neuroinflammation; it can persist inside cells for years.
  • Yersinia enterocolitica: gastrointestinal symptoms, joint pain and autoimmune thyroid conditions.
  • Candida and fungal overgrowth: prolonged antibiotic use and immune suppression promote fungal overgrowth that is managed during and after the antibiotic weeks.

Our testing panel

The co-infection panel tests for all of the above pathogens with a combination of serological, molecular and cellular immune tests in the hospital laboratory. Physicians who treat tick-borne illness every day read the results and write the plan for every identified infection.

How we work

Treating the full infection spectrum

At St. George Hospital, co-infection treatment is not an afterthought. It is an integral part of every Lyme disease treatment plan. Our approach recognizes that treating Borrelia alone while co-infections persist will never achieve lasting improvement.

The primary treatment for co-infections is Intravenous Low-Level Laser Therapy (LLLT), delivered as 10 sessions in the dedicated Co-Infection Module. A fiber-optic catheter is inserted into a peripheral vein, delivering laser light directly into the bloodstream. The therapy stimulates mitochondrial function and ATP synthesis at the cellular level. Six wavelengths target different therapeutic effects: blue (405 nm) with Riboflavin for antimicrobial action against Bartonella, Babesia, and intracellular pathogens; green (532 nm) for improved oxygen uptake via hemoglobin binding; yellow (589 nm) for detoxification and serotonin metabolism support; red (635 nm) for deep tissue anti-inflammatory effect and microcirculation improvement; infrared (810 nm) for deepest tissue penetration (5–7 cm) and stem cell activation; and UV light for immune activation and direct pathogen inactivation. This is combined with apheresis blood purification, and in severe cases, Plasma Exchange or Red Blood Cell Exchange.

Our complete co-infection treatment strategy includes:

  • Full testing for all major co-infections before treatment begins
  • 10 I.V. Laser Therapy (PDT) sessions with multiple wavelengths targeting different pathogens
  • Apheresis blood purification, including Plasma Exchange or red blood cell exchange for severe cases
  • Targeted antimicrobial protocols specific to each identified pathogen
  • Whole-body hyperthermia, which has broad antimicrobial effects across multiple pathogen types
  • Immune restoration to support the body's ability to clear persistent intracellular organisms
  • Monitoring and re-testing to confirm treatment response for each co-infection

For patients from abroad, the co-infection module is scheduled as part of inpatient Lyme disease treatment in Germany: a video consultation in English before you travel, the work-up in the first days, and the antimicrobial plan for each pathogen written from it.

Fibre applicator in a forearm cannula during intravenous laser therapy
Intravenous laser therapy, part of the co-infection module. Clinicum St. Georg
Evidence

Evidence and limits

The evidence is graded by claim. That ticks and tick-borne disease are polymicrobial, so that a Borrelia-only work-up can miss a second organism, is strong (Sanchez-Vicente et al., 2019; Nijjar et al., 2024). The treatment of babesiosis with antiparasitic combinations rests on a guideline (Krause et al., 2021), and doxycycline for Ehrlichia and Anaplasma is standard care. The evidence for intravenous laser therapy and apheresis in co-infections is limited.

In our clinical experience since 1995, an untreated co-infection is the most frequent finding in patients whose symptoms continued after a Lyme-only course. That is an observation from the ward, not a trial result, and it is why the co-infection panel is part of every Lyme work-up here.

What we document

  • Which co-infections were confirmed, by which test
  • The agents used for each, with dates
  • Re-testing after the module and at follow-up
  • Symptom scores before and after, in the report for your home physician
Related therapies

Treatments for Lyme Co-Infections

Ozone therapy

Medical ozone has direct antimicrobial properties against co-infection organisms and enhances immune function.

What ozone therapy involves →

Immune therapy

Thymus peptides and micronutrient infusions to support the immune response against persistent intracellular organisms.

What immune therapy involves →
Frequently asked questions

Questions about Lyme co-infections

Is Babesia Lyme disease?

No. Babesia is a parasite of red blood cells, related to the malaria parasite, and Lyme disease is caused by the bacterium Borrelia. The same Ixodes tick can transmit both, which is why they are often found together. Babesia does not respond to the antibiotics used for Borrelia and needs antiparasitic treatment of its own.

How do you test for Bartonella and Babesia?

Babesia is looked for in the blood smear and by PCR, with serology as a second line. Bartonella is tested by serology and PCR; both can be negative in a long-standing infection, so the result is read with the symptom pattern. Both tests are part of the co-infection panel in the hospital laboratory.

Does doxycycline treat Babesia?

No. Doxycycline is the first-line agent for Ehrlichia and Anaplasma and is used in Lyme disease, but Babesia is a parasite and is treated with antiparasitic combinations such as atovaquone with azithromycin, following the babesiosis guideline. A patient treated only with doxycycline keeps the Babesia.

Can co-infections be treated at the same time as Lyme disease?

Yes. In the program the core Lyme module comes first and the co-infection module follows, with antimicrobial agents chosen for each confirmed pathogen, intravenous laser therapy and apheresis. Whole-body hyperthermia belongs to the Lyme module and is not repeated for the co-infections.

Which co-infections are in your panel?

Bartonella, Babesia, Ehrlichia, Anaplasma, Rickettsia, Chlamydia pneumoniae, Mycoplasma pneumoniae and Yersinia. The panel combines serological, molecular and cellular immune tests and is part of every Lyme work-up at the hospital.

References

  1. Polymicrobial Nature of Tick-Borne Diseases. mBio 2019. PMID 31506314
  2. Prevalence of Babesia microti Co-Infection with Other Tick-Borne Pathogens in Pennsylvania. Microorganisms 2024. PMID 39597609
  3. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis 2021. PMID 33501959
  4. Bartonella spp. transmission by ticks not established. Emerg Infect Dis 2010. PMID 20202410

Send a free inquiry

The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.

Hours
Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.

Munich Airport (MUC), about 60 minutes by car.

CallSend a free inquiry